CPQ and amyotrophic lateral sclerosis: In an attempt to identify biomarkers with metabolic activity, this work develops a systematic investigation of a type of proteolytic enzymes, aminopeptidases, which comprise the main pathways (cytoplasmic membrane and lysosomal) of CNS and systemic intracellular protein degradation from patients with ALS.